Home › Keryx pill for kidney disease patients cleared, but with safety warnings attached, shares fall
 

Keywords :   


Keryx pill for kidney disease patients cleared, but with safety warnings attached, shares fall

2014-09-05 22:05:57| Biotech - Topix.net

Keryx Biopharmaceuticals shares fell Friday as the company received U.S. approval for its pill to treat kidney disease complications but the clearance required unexpected safety warnings. The Food and Drug Administration approved the company's ferric citrate drug to treat patients on dialysis with hyperphosphatemia, or elevated levels of phosphates, which can increase the risk of heart disease, bone density problems and death.

Tags: fall safety attached disease

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
16.05Who is Paula Vennells? Ex-Post Office boss in Horizon IT inquiry
16.05BASF Expands Biomass Balance Portfolio for Selected Chemical Intermediates
16.05Dow and SCGC Partner to Change 200KTA of Plastic Waste Into Circular Products
16.05Leanpath Uses Generative AI to Drive Action on Food Waste Data
16.05AkzoNobels Como Site Achieves Highest Automotive Industry Quality Certification
16.05ECONWARDs Counterplan for Landfill-Bound Organics
16.05Mortgage rates cut but borrowing pressures remain
16.05Coca-Cola Completes Transition to 100% Recycled Plastic for Bottles in Canada
More »